Trial NCT00458276

View at ClinicalTrials.gov 
Org. Study IDs: AC-051-350

Last trial update was posted on 2018-07-09

MeSH Interventions

Tezosentan

MeSH Conditions

Heart Diseases Hypertension Hypertension, Pulmonary

Other Conditions


Stopping Reasons

6 month vital status report not collected after 28 day follow up analysis indicated no difference between placebo & tezosentan

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID